Home Virology Coronavirus $500M Merger Boosts NeuroRx VIP Guided Missile vs. COVID-19

Concept of SARS-CoV-2 or 2019-ncov coronavirus — Source: Maksim Tkachenko/Getty Images

$500M Merger Boosts NeuroRx VIP Guided Missile vs. COVID-19

By Alex Philippidis

-

December 30, 2020

Source: Maksim Tkachenko/Getty Images

NeuroRx says combination with Big Rock will help develop lead drugs against SARS-CoV-2 and bipolar depression . . .

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge

MORE STORIES